Volume 80, Issue 1, Pages (July 2011)

Slides:



Advertisements
Similar presentations
Management of IgA nephropathy: Evidence-based recommendations
Advertisements

Volume 54, Issue 2, Pages (August 1998)
Linear and logistic regression analysis
No difference in bleeding risk between subcutaneous enoxaparin and heparin for thromboprophylaxis in end-stage renal disease  Kevin E. Chan, Ravi I. Thadhani,
Determinants of phosphorus mobilization during hemodialysis
Jean-Claude Davin, Ineke J. Ten Berge, Jan J. Weening 
Volume 80, Issue 10, Pages (November 2011)
Volume 78, Pages S41-S45 (August 2010)
Volume 67, Issue 2, Pages (February 2005)
Joel D. Kopple, Xiaofei Zhu, Nancy L. Lew, Edmund G. Lowrie 
Peripheral microvascular parameters in the nephrotic syndrome
Volume 65, Issue 2, Pages (February 2004)
How to interpret the eGFR in patients with small body surface area
Methotrexate in the urine
Comorbidity and confounding in end-stage renal disease
Volume 86, Issue 1, Pages (July 2014)
Volume 74, Issue 3, Pages (August 2008)
Punit Yadav, Nelson Leung, Paul W. Sanders, Paul Cockwell 
Volume 76, Issue 8, Pages (October 2009)
Volume 77, Issue 2, Pages (January 2010)
Transplantation rates for living- but not deceased-donor kidneys vary with socioeconomic status in Australia  Blair S. Grace, Philip A. Clayton, Alan.
Long-term study of mycophenolate mofetil treatment in IgA nephropathy
Volume 87, Issue 2, Pages (February 2015)
Joanna K. Boyd, Jonathan Barratt  Kidney International 
Volume 75, Issue 12, Pages (June 2009)
U-shaped effect of eGFR and mortality
Volume 74, Issue 9, Pages (November 2008)
The calcium–phosphorus in guidelines for CKD-MBD
Frank Eitner, Jürgen Floege  Kidney International 
Volume 76, Issue 5, Pages (September 2009)
Volume 56, Issue 4, Pages (October 1999)
Should kidney donors be genotyped for APOL1 risk alleles?
Volume 75, Issue 12, Pages (June 2009)
Capturing the in vivo molecular signature of the podocyte
Volume 87, Issue 1, Pages (January 2015)
A physician's perseverance uncovers problems in a key nephrology study
Volume 80, Issue 7, Pages (October 2011)
Volume 61, Issue 6, Pages (June 2002)
Volume 71, Issue 11, Pages (June 2007)
Extracorporeal therapy in sepsis: are we there yet?
Volume 69, Issue 12, Pages (June 2006)
Volume 69, Issue 3, Pages (February 2006)
Urinary biomarkers: the future looks promising
Alternate-day dialysis may be needed for hemodialysis patients
Nephrology Crossword: Peritoneal Dialysis
IgA nephropathy at two score and one
Volume 76, Issue 1, Pages (July 2009)
Volume 85, Issue 1, Pages (January 2014)
Nephrology Crossword: Glomerulonephritis
Volume 60, Issue 3, Pages (September 2001)
Volume 74, Issue 5, Pages (September 2008)
Volume 69, Issue 8, Pages (April 2006)
Michael W. Steffes, Derek Schmidt, Rebecca Mccrery, John M. Basgen 
Volume 79, Issue 1, Pages (January 2011)
Homocysteine, renal function, and risk of cardiovascular disease
Volume 82, Issue 7, Pages (October 2012)
Volume 82, Issue 9, Pages (November 2012)
The treatment of acute interstitial nephritis: More data at last
Volume 68, Issue 1, Pages (July 2005)
Serum cystatin C-immunoglobulin high-molecular-weight complexes in kidney and liver transplant patients  Jesús Hermida, Rafael Romero, J. Carlos Tutor 
Volume 74, Issue 9, Pages (November 2008)
Atherosclerotic nephropathy
Volume 63, Issue 3, Pages (March 2003)
Volume 80, Issue 10, Pages (November 2011)
Dana V. Rizk, David G. Warnock  Kidney International 
The international realities of live donor kidney transplantation
The International Pediatric Peritonitis Registry: Starting to walk
Volume 80, Issue 9, Pages (November 2011)
Longitudinal relationships between diet-dependent renal acid load and blood pressure development in healthy children  Danika Krupp, Lijie Shi, Thomas.
Sugar-sweetened beverages and chronic disease
Presentation transcript:

Volume 80, Issue 1, Pages 79-87 (July 2011) Aberrant glycosylation of IgA1 is inherited in both pediatric IgA nephropathy and Henoch–Schönlein purpura nephritis  Krzysztof Kiryluk, Zina Moldoveanu, John T. Sanders, T. Matthew Eison, Hitoshi Suzuki, Bruce A. Julian, Jan Novak, Ali G. Gharavi, Robert J. Wyatt  Kidney International  Volume 80, Issue 1, Pages 79-87 (July 2011) DOI: 10.1038/ki.2011.16 Copyright © 2011 International Society of Nephrology Terms and Conditions

Figure 1 Serum total immunoglobulin A (IgA) and galactose-deficient IgA1 (Gd-IgA1) levels in pediatric cases, pediatric controls, and adult controls. Correlations between (a) serum total IgA and Gd-IgA1; (b) age and serum total IgA; and (c) age and serum Gd-IgA1. Pearson's correlation coefficients with corresponding P-values are depicted above each graph. NS, not significant. Kidney International 2011 80, 79-87DOI: (10.1038/ki.2011.16) Copyright © 2011 International Society of Nephrology Terms and Conditions

Figure 2 Serum galactose-deficient immunoglobulin A1 (Gd-IgA1) and total IgA levels as predictors of pediatric IgA nephropathy (IgAN) and Henoch–Schönlein purpura nephritis (HSPN). (a) Crude (unadjusted) serum Gd-IgA1 levels in children with HSPN, IgAN, and healthy pediatric controls (P-values: the Mann–Whitney U-test); (b) age- and gender-adjusted trait values expressed as standardized residuals of log-transformed Gd-IgA1 regressed against age and sex (P-values: Student's t-test); and (c) receiver operating characteristics curves for serum Gd-IgA1 and total serum IgA in pediatric IgAN and (d) pediatric HSPN. Kidney International 2011 80, 79-87DOI: (10.1038/ki.2011.16) Copyright © 2011 International Society of Nephrology Terms and Conditions

Figure 3 Serum galactose-deficient immunoglobulin A1 (Gd-IgA1) levels in first-degree relatives. (a) Parents of children with Henoch–Schönlein purpura nephritis (HSPN) and IgA nephropathy (IgAN) versus healthy adult controls; (b) cases of HSPN, their parents, and healthy pediatric controls; (c) pediatric cases of IgAN, their parents, and healthy pediatric controls; (d) serum Gd-IgA1 levels in first-degree relatives versus index cases; and (e) serum Gd-IgA1 levels in healthy adult controls compared with first-degree relatives after stratification by Gd-IgA1 in the index cases (high level in index cases was defined as >95th percentile for a group of pediatric controls, whereas high level in relatives was defined as >95th percentile for a group of adult controls). NS, not significant. Kidney International 2011 80, 79-87DOI: (10.1038/ki.2011.16) Copyright © 2011 International Society of Nephrology Terms and Conditions